An interventional study of Prp with prf or prp or prf in Osteoarthritis, sponsored by Aliaa Babekir Ahmed Mohamed. Completed at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2025-12-12.
Sponsored by Aliaa Babekir Ahmed Mohamed · Not applicable, Interventional, and Treatment
Studying effectiveness of prp with prf comparing with prp or prf for mangement of tmj osteoarthritis as result in pain and mandibular movement in adult pt
45 pt assigned for the study , divided in to three gruops to comparing new combination of prp with prf in management of TMJ OA
4,398 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.
This study's enrollment of 42 is below the median of 70 across 3,440 interventional studies indexed under Osteoarthritis.
Browse Osteoarthritis studies →This is the only study on the registry with Aliaa Babekir Ahmed Mohamed as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Adult pt with OA
Exclusion Criteria:
Medicaly compromised
Pt will recievd prp with prf
Combination Product: Prp with prf or prp or prf
Pt will recieve prp only
Combination Product: Prp with prf or prp or prf
Pt will recieve prf only
Combination Product: Prp with prf or prp or prf
Combination
Pain severty
Visual analog scale measure for pain most sever pain take 10 minimum pain take 0
Time frame: 6 months
Maximum mouth opening
Measured with calipar
Time frame: 6 months
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.